Skip to main content
. 2022 Jan 7;12:193. doi: 10.1038/s41598-021-03272-1

Table 4.

Characteristics of patients with HCC development.

Patients No Sex/age HCC occurrence Baseline LS LS at 48 week LS at 96 week LS at 144 week
1 M/59 96 weeks 38.0 28.4 (− 25.3%) 26.7 (−29.7%)
2 F/76 96 weeks 32.1 25.1 (− 21.8%) 35.0 (+ 0.09%)
3 M/69 96 weeks 45.0 39.0 (−13.3%) 13.4 (−70.2%)
4 F/75 144 weeks 25.7 20.0 (−22.2%) 14.5 (−43.6%) 19.8
5 M/63 144 weeks 17.6 12.0 (−31.8%) 9.7 (−44.9%) 10.5

HCC, hepatocellular carcinoma; LS, liver stiffness.